The Promise of Digital Biopsy for the Prediction of Tumor Molecular Features and Clinical Outcomes Associated With Immunotherapy
Open Access
- 31 July 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 6, 172
Abstract
Immunotherapy by immune checkpoint inhibitors has emerged as an effective treatment for a slight proportion of patients with aggressive tumors. Currently, some molecular determinants, such as the expression of the programmed cell death ligand-1 (PD-L1) or the tumor mutational burden (TMB) have been used in the clinical practice as predictive biomarkers, although they fail in consistency, applicability, or reliability to precisely identify the responding patients mainly because of their spatial intratumoral heterogeneity. Therefore, new biomarkers for early prediction of patient response to immunotherapy, that could integrate several approaches, are eagerly sought. Novel methods of quantitative image analysis (such as radiomics or pathomics) might offer a comprehensive approach providing spatial and temporal information from macroscopic imaging features potentially predictive of underlying molecular drivers, tumor-immune microenvironment, tumor-related prognosis, and clinical outcome (in terms of response or toxicity) following immunotherapy. Preliminary results from radiomics and pathomics analysis have demonstrated their ability to correlate image features with PD-L1 tumor expression, high CD3 cell infiltration or CD8 cell expression, or to produce an image signature concordant with gene expression. Furthermore, the predictive power of radiomics and pathomics can be improved by combining information from other modalities, such as blood values or molecular features, leading to increase the accuracy of these models. Thus, “digital biopsy,” which could be defined by non-invasive and non-consuming digital techniques provided by radiomics and pathomics, may have the potential to allow for personalized approach for cancer patients treated with immunotherapy.Keywords
Funding Information
- Hôpitaux Universitaires de Genève
This publication has 42 references indexed in Scilit:
- Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approachNature Communications, 2014
- Dynamic contrast‐enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancerNMR in Biomedicine, 2014
- Quantitative Imaging in Cancer Evolution and EcologyRadiology, 2013
- MR Imaging Predictors of Molecular Profile and Survival: Multi-institutional Study of the TCGA Glioblastoma Data SetRadiology, 2013
- Radiomics: the process and the challengesMagnetic Resonance Imaging, 2012
- Biological imaging software toolsNature Methods, 2012
- Integrated morphologic analysis for the identification and characterization of disease subtypesJournal of the American Medical Informatics Association, 2012
- Genomic analysis: Toward a new approach in breast cancer managementCritical Reviews in Oncology/Hematology, 2012
- Radiomics: Extracting more information from medical images using advanced feature analysisEuropean Journal of Cancer, 2012
- Maintenance therapy in NSCLC: why? To whom? Which agent?Journal of Experimental & Clinical Cancer Research, 2011